1.67
0.60%
-0.01
After Hours:
1.65
-0.02
-1.20%
180 Life Sciences Corp stock is traded at $1.67, with a volume of 16,113.
It is down -0.60% in the last 24 hours and down -7.73% over the past month.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
See More
Previous Close:
$1.68
Open:
$1.67
24h Volume:
16,113
Relative Volume:
0.03
Market Cap:
$1.71M
Revenue:
-
Net Income/Loss:
$-19.94M
P/E Ratio:
-0.0697
EPS:
-23.95
Net Cash Flow:
$-10.92M
1W Performance:
-10.22%
1M Performance:
-7.73%
6M Performance:
-28.33%
1Y Performance:
-85.65%
180 Life Sciences Corp Stock (ATNF) Company Profile
Name
180 Life Sciences Corp
Sector
Industry
Phone
650-507-0669
Address
3000 EL CAMINO REAL, PALO ALTO
180 Life Sciences Corp Stock (ATNF) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-15-21 | Initiated | Maxim Group | Buy |
180 Life Sciences Corp Stock (ATNF) Latest News
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.09% - MSN
Amalgamated Bank Increases Stake in Atlantic Union Bankshares Co. (NASDAQ:AUB) - Defense World
Layoff Tracker: Bluebird Bio to Cut 25% of Workforce and More News - BioSpace
What Goldman Sachs’s 2,600 interns think about AI - Fortune
ChromaDex appoints new CFO Ozan Pamir - Investing.com
ChromaDex appoints new CFO Ozan Pamir - Investing.com India
ChromaDex Appoints Ozan Pamir As Chief Financial Officer - citybiz
ChromaDex Appoints Ozan Pamir as Chief Financial Officer - Business Wire
Life Time Group Holdings Inc [LTH] Member of 10% Owner Group makes an insider sale of 650,000 shares worth 13,572,000. – Knox Daily - Knox Daily
Review: ANTICHRIST - FANGORIA
Herbalife Ltd. (NYSE:HLF) Sees Large Decline in Short Interest - Defense World
360 One WAM board approves fundraise of worth Rs 2,250 crore via QIP - Moneycontrol
360 ONE WAM boards OKs raising funds up to Rs 2,250 crore via QIP route - Business Standard
InnovAge (NASDAQ:INNV) Trading Up 4.2% - Defense World
Hamilton Lane (NASDAQ:HLNE) Hits New 1-Year High at $162.25 - MarketBeat
Hippo Holdings Inc. (NYSE:HIPO) Short Interest Update - MarketBeat
Quantum Blockchain Technologies (LON:QBT) Trading 10.5% Higher - Defense World
Bloomin’ Brands (NASDAQ:BLMN) Trading Down 3.2% - Defense World
Life360 Set to Join Russell 2000® and 3000® Indexes - The Tech Outlook
Deeper Dive: Understanding Herbalife Ltd (HLF) Through its Various Ratios - The Dwinnex
Instil Bio Inc (TIL) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
Instil Bio Stock Skyrockets 641% in One Week: Here's Why - Yahoo Finance
Instil Bio price target raised to $120 from $40 at H.C. Wainwright - TipRanks
Up More Than 500% in 2024. Can Instil Bio Keep Rocketing Higher? - sharewise
Key Milestone in India’s Clinical Research Ecosystem: ICMR To Begin First-In-Human Clinical Trials for 4 Promising Molecules - IndianWeb2.com
Up More Than 500% in 2024. Can Instil Bio Keep Rocketing Higher? - AOL
Egle names Detheux chairman - BioCentury
Illinois Tool Works Inc. stock outperforms competitors on strong trading day - MarketWatch
Financial Fitness Check: Examining Herbalife Ltd (HLF)’s Key Ratios - The Dwinnex
180 Life Sciences Announces CFO Resignation and New Board Appointments - TipRanks
180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer - ForexTV.com
180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer Seite 112.09.2024 - wallstreet:online
180 Life Sciences Announces the Appointment of Omar Jimenez as Chief Financial Officer - StockTitan
180 Life Sciences Corp. finalizes separation with former executive - Investing.com
United States shares mixed at close of trade; Dow Jones Industrial Average up 0.09% - MSN
ATNF’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - The InvestChronicle
Why Modular Medical Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket - Benzinga
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.09% - Mitrade
Spark Therapeutics CEO departs to lead another life sciences company - The Business Journals
Abrdn Life Sciences Investors (NYSE:HQL) Shares Sold by Allspring Global Investments Holdings LLC - Defense World
Zydus Lifesciences Shares Surge 4% on USFDA Final Approval - EquityPandit
Assenagon Asset Management S.A. Decreases Stock Position in Illumina, Inc. (NASDAQ:ILMN) - Defense World
180 Life Sciences (NASDAQ:ATNF) Stock Quotes, Forecast and News Summary - Benzinga
NIH grants funds to Boston Immune’s Phase I trial of TNFR2 antagonist - Clinical Trials Arena
ATNF (180 Life Sciences) 3-Year EPS without NRI Growth Rate : 41.70% (As of Jun. 2024) - GuruFocus.com
HTGMQ (HTG Molecular Diagnostics) Float Percentage Of Total Shares Outstanding : 99.92% (As of Aug. 18, 2024) - GuruFocus.com
Baker Tilly Wealth Management LLC Has $236,000 Holdings in Illumina, Inc. (NASDAQ:ILMN) - Defense World
ATNF (180 Life Sciences) EV-to-Revenue : (As of Aug. 17, 2024) - GuruFocus.com
Q3 2024 EPS Estimates for Edwards Lifesciences Co. (NYSE:EW) Decreased by Zacks Research - Defense World
SELLAS Life Sciences Group (NASDAQ:SLS) Issues Quarterly Earnings Results - Defense World
Kezar Life Sciences, Inc. (NASDAQ:KZR) to Post Q3 2024 Earnings of ($0.30) Per Share, William Blair Forecasts - Defense World
180 Life Sciences Corp Stock (ATNF) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):